MRSN
Price
$8.20
Change
-$0.08 (-0.97%)
Updated
Oct 6 closing price
Capitalization
40.92M
35 days until earnings call
SLXN
Price
$3.87
Change
-$0.06 (-1.53%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
12.1M
Interact to see
Advertisement

MRSN vs SLXN

Header iconMRSN vs SLXN Comparison
Open Charts MRSN vs SLXNBanner chart's image
Mersana Therapeutics
Price$8.20
Change-$0.08 (-0.97%)
Volume$32.73K
Capitalization40.92M
Silexion Therapeutics
Price$3.87
Change-$0.06 (-1.53%)
Volume$237
Capitalization12.1M
MRSN vs SLXN Comparison Chart in %
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRSN vs. SLXN commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSN is a Buy and SLXN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (MRSN: $8.20 vs. SLXN: $3.87)
Brand notoriety: MRSN and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRSN: 47% vs. SLXN: 11%
Market capitalization -- MRSN: $40.92M vs. SLXN: $12.1M
MRSN [@Biotechnology] is valued at $40.92M. SLXN’s [@Biotechnology] market capitalization is $12.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRSN’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • MRSN’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, MRSN is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRSN’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • MRSN’s TA Score: 5 bullish, 4 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both MRSN and SLXN are a good buy in the short-term.

Price Growth

MRSN (@Biotechnology) experienced а +5.26% price change this week, while SLXN (@Biotechnology) price change was +14.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +14.77%, and the average quarterly price growth was +84.62%.

Reported Earning Dates

MRSN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRSN($40.9M) has a higher market cap than SLXN($12.1M). MRSN YTD gains are higher at: -77.063 vs. SLXN (-87.164). SLXN has higher annual earnings (EBITDA): -17.81M vs. MRSN (-68.88M). MRSN has more cash in the bank: 77M vs. SLXN (3.47M). SLXN has less debt than MRSN: SLXN (3.7M) vs MRSN (20.6M). MRSN has higher revenues than SLXN: MRSN (34.8M) vs SLXN (0).
MRSNSLXNMRSN / SLXN
Capitalization40.9M12.1M338%
EBITDA-68.88M-17.81M387%
Gain YTD-77.063-87.16488%
P/E RatioN/AN/A-
Revenue34.8M0-
Total Cash77M3.47M2,222%
Total Debt20.6M3.7M557%
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRSNSLXN
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
13%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
29%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
28%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
55%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 6 days ago
53%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
50%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNCE3.280.15
+4.79%
VINCE HOLDING Corp
ARM156.223.58
+2.35%
Arm Holdings plc
CLF12.64-0.11
-0.86%
Cleveland-Cliffs
AVNW22.58-0.21
-0.92%
Aviat Networks
BV13.44-0.46
-3.31%
BrightView Holdings

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.53%
IMA - SLXN
62%
Loosely correlated
+0.12%
CELC - SLXN
50%
Loosely correlated
-5.36%
MRSN - SLXN
43%
Loosely correlated
-0.97%
CHRS - SLXN
26%
Poorly correlated
+3.66%
QSI - SLXN
25%
Poorly correlated
+5.23%
More